<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Immunology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Immunology</journal-title><trans-title-group xml:lang="ru"><trans-title>Russian Journal of Immunology</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1028-7221</issn><issn publication-format="electronic">2782-7291</issn><publisher><publisher-name xml:lang="en">Russian Society of Immunology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">8003</article-id><article-id pub-id-type="doi">10.46235/1028-7221-8003-DOA</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Development of a model immunofiltration assay using a conjugate based on horseradish peroxidase</article-title><trans-title-group xml:lang="ru"><trans-title>Разработка модельного иммунофильтрационного анализа с использованием конъюгата на основе пероксидазы хрена</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7068-2789</contrib-id><name-alternatives><name xml:lang="en"><surname>Kropaneva</surname><given-names>Mariya D.</given-names></name><name xml:lang="ru"><surname>Кропанева</surname><given-names>Мария Дмитриева</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Junior Research Associate, Laboratory of Cell Immunology and Biotechnology</p></bio><bio xml:lang="ru"><p>кандидат биологических наук , младший научный сотрудник лаборатории клеточной иммунологии и биотехнологии</p></bio><email>kropanevamasha@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khramtsov</surname><given-names>Pavel Viktorovich V.</given-names></name><name xml:lang="ru"><surname>Храмцов</surname><given-names>Павел Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Senior Research Associate, Laboratory of Cell Immunology and Biotechnology</p></bio><bio xml:lang="ru"><p>кандидат биологических наук , старший научный сотрудник лаборатории клеточной иммунологии и биотехнологии, Институт экологии и генетики микроорганизмов</p></bio><email>khramtsovpavel@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bochkova</surname><given-names>Mariya S.</given-names></name><name xml:lang="ru"><surname>Бочкова</surname><given-names>Мария Станиславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Research Associate, Laboratory of Cell Immunology and Biotechnology</p></bio><bio xml:lang="ru"><p>кандидат биологических наук , научный сотрудник лаборатории клеточной иммунологии и биотехнологии</p></bio><email>krasnykh-m@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rayev</surname><given-names>Mikhail Borisovich B.</given-names></name><name xml:lang="ru"><surname>Раев</surname><given-names>Михаил Борисович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Biology), Head, Laboratory of Cell Immunology and Biotechnology</p></bio><bio xml:lang="ru"><p>доктор биологических наук , заведующий лабораторией клеточной иммунологии и биотехнологии</p>
<p> </p></bio><email>mraev@iegm.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Ecology and Genetic of Microorganisms, Perm Federal Research Center, Ural Branch, Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт экологии и генетики микроорганизмов Уральского отделения Российской академии наук – филиал ФГБУН «Пермский федеральный исследовательский центр Уральского отделения Российской академии наук»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-08-11" publication-format="electronic"><day>11</day><month>08</month><year>2023</year></pub-date><volume>26</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>313</fpage><lpage>320</lpage><history><date date-type="received" iso-8601-date="2023-04-28"><day>28</day><month>04</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-06-29"><day>29</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Kropaneva M.D., Khramtsov P.V., Bochkova M.S., Rayev M.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Кропанева М.Д., Храмцов П.В., Бочкова М.С., Раев М.Б.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Kropaneva M.D., Khramtsov P.V., Bochkova M.S., Rayev M.B.</copyright-holder><copyright-holder xml:lang="ru">Кропанева М.Д., Храмцов П.В., Бочкова М.С., Раев М.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://rusimmun.ru/jour/article/view/8003">https://rusimmun.ru/jour/article/view/8003</self-uri><abstract xml:lang="en"><p>The aim of the study was to optimize the conditions for a model immunoassay in the immunofiltration format using diagnostic reagents based on horseradish peroxidase. Residual blood serum samples from patients in the “red” zone with a verified diagnosis of a new coronavirus infection were used as positive sera, and blood sera obtained before 2019 were used as negative samples. The procedure of immunofiltration analysis was carried out using a pool of negative and positive blood sera. Studies were carried out to optimize the analysis procedure and increase the significant characteristics of the test. Results. It has been shown that the addition of sodium dodecyl sulfate to a final concentration of 50 μM in the substrate buffer makes it possible to achieve a higher analytical signal and a stable result 10 minutes after the end of the analysis procedure. Such conditions of immunofiltration analysis as dilutions of the diagnostic reagent, the volume of the introduced sample and the amount of the S-protein of the coronavirus applied to the nitrocellulose membrane were optimized. It has been determined that using immunofiltration analysis it is possible to detect antibodies against the coronavirus S-protein in a dilution of a serum sample of more than 1/1000. The results of immunofiltration analysis reproduce the results of ELISA.</p></abstract><trans-abstract xml:lang="ru"><p>Целью исследования явилась оптимизация условий для модельного иммуноанализа в формате иммунофильтрации с использованием диагностических реагентов на основе пероксидазы хрена. В качестве положительных сывороток в работе использовали остаточные образцы сыворотки крови пациентов «красной» зоны, с верифицированным диагнозом новой коронавирусной инфекции, в качестве отрицательных образцов были использованы сыворотки крови, полученные до 2019 года. Процедуру иммунофильтрационного анализа осуществляли с применением пула отрицательных и положительных сывороток крови.Были проведены исследования, опитимизирующие процедуру анализа и повышающие значимые характеристики теста. Результаты. Показано, что добавление додецилсульфата натрия до конечной концентрации 50 мкМ в субстратный буфер позволяет достичь более высокого аналитического сигнала и стабильного результата спустя 10 минут после окончания процедуры анализа. Оптимизированы такие условия иммунофильтрационного анализа как разведения диагностического реагента, объем вносимого образца и количество S-белка коронавируса, наносимого на нитроцеллюлозную мембрану. Определено, что с помощью иммунофильтрационного анализа возможно определение антител против S-белка коронавируса в разведении образца сыворотки более чем 1/1000. Результаты иммунофильтрационного анализа воспроизводят результаты ИФА.</p></trans-abstract><kwd-group xml:lang="en"><kwd>coronavirus infection COVID-19</kwd><kwd>horseradish peroxidase</kwd><kwd>immunofiltration assay</kwd><kwd>laboratory diagnostics</kwd><kwd>enzyme immunoassay</kwd><kwd>point-of-care test-system</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>коронавирусная инфекция COVID-19</kwd><kwd>пероксидаза хрена</kwd><kwd>иммунофильтрационный анализ</kwd><kwd>лабораторная диагностика</kwd><kwd>иммуноферментный анализ</kwd><kwd>point-of-care тест-системы</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Государственное задание, регистрационный номер НИОКТР 122010800029-1</institution></institution-wrap><institution-wrap><institution xml:lang="en">State assignment</institution></institution-wrap></funding-source><award-id>122010800029-1</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Adil B., Shankar K.M., Naveen Kumar B.T., Patil R., Ballyaya A., Ramesh K.S., Poojary S.R., Byadgi O.V., Siriyappagouder P. Development and standardization of a monoclonal antibody-based rapid flow-through immunoassay for the detection of Aphanomyces invadans in the field // J Vet Sci, 2013, Vol. 14, no. 4. pp. 413-419.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Castro A.R., Mody H.C., Parab S.Y., Patel M.T., Kikkert S.E., Park M.M., Ballard R.C. An immunofiltration device for the simultaneous detection of non-treponemal and treponemal antibodies in patients with syphilis. STI, 2010, Vol. 86, no. 7, pp. 532-536.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ernst E., Wolfe P., Stahura C., Edwards K.A. Technical considerations to development of serological tests for SARS-CoV-2. Talanta, 2021, Vol. 224, pp. 121883. . DOI: 10.1016/j.talanta.2020.121883</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Kalita P, Chaturvedula L.M., Sritharan V, Gupta S. In vitro flow-through assay for rapid detection of endotoxin in human sera: A proof-of-concept. Nanomedicine: NBM, 2017. Vol. 13, no. 4. pp.1483-1490.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Khramtsov, P., Bochkova M., Timganova V, Zamorina S., Rayev M. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus. Anal Bioanal Chem, 2017, Vol. 409, pp.3831–3842.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Komkova M.A., Vetoshev K.R., Andreev E.A., Karyakin A.A. Flow-electrochemical synthesis of Prussian Blue based nanozyme 'artificial peroxidase'. Dalton Transactions, 2021, Vol. 50, no. 133, pp. 11385-11389.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Li M., He Yif., Meng H., Dong Y., Shang Y., Liu H., Qu Z., Liu Y. Multiple effects of sodium dodecyl sulfate on chromogenic catalysis of tetramethylbenzidine with horseradish peroxidase. J. Dispers. Sci., 2019, Vol. 45, no 3. pp. 1409-1416.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Oishee M.J., Ali T., Jahan N., Khandker S.S., Haq M.A., Khondoker M.U., Sil B.K., Lugova H., Krishnapillai A., Abubakar A.R., Kumar S., Haque, M. Jamiruddin, M.R. Adnan, N. Covid-19 pandemic: Review of contemporary and forthcoming detection tools. Infect. Drug Resist., 2021, Vol. 14, pp. 1049-1082. DOI: 10.2147/IDR.S289629</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Panferov V.G., Safenkova I.V., Zherdev A.V., Dzantiev B.B. The steadfast Au@Pt soldier: Peroxide-tolerant nanozyme for signal enhancement in lateral flow immunoassay of peroxidase-containing samples. Talanta, 2021, Vol. 225, pp. 121961.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Pérez-López B., Mir M. Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages. Talanta, 2021, Vol. 225, pp. 121898.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Robertson L.J., Moore J.S., Blighe K., Ng K.Y., Quinn N., Jennings F., Warnock G., Sharpe P., Clark M., Maguire K., Rainey S., Price R.K., Burns W.P., Kowalczyk A.M., Awuah A., Mcnamee S.E., Wallace G.E., Hunter D., Sager S., Chao Shern C., Nesbit M.A., Mclaughlin J.A.D., Moore T. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months. BMJ Open, 2021, Vol. 11, no. 6, pp. 048142.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ross G.M.S., Filippini D., Nielen M.W.F., Salentijn G.I.J. Unraveling the Hook Effect: A Comprehensive Study of High Antigen Concentration Effects in Sandwich Lateral Flow Immunoassays. Anal. Chem., 2020, Vol. 92, no. 23, pp. 15587-15595.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ross G.M.S., Salentijn G.I., Nielen M.W.F. A Critical Comparison between Flow-through and Lateral Flow Immunoassay Formats for Visual and Smartphone-Based Multiplex Allergen Detection. Biosensors (Basel), 2019; Vol. 9, no. 4, pp. 143.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Tsang V., Greene R. M., Pilcher J. B. Optimization of the Covalent Conjugating Procedure (NaIO4) of Horseradish Peroxidase to Antibodies for Use in Enzyme-Linked Immunosorbent Assay. J. Immunoass., 1995, Vol. 16, no. 4. pp 395-418.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol, 2021, Vol. 19, no. 3, pp. 171-183.</mixed-citation></ref></ref-list></back></article>
